We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

CellTiter-Glo® 2.0 Assay

CellTiter2_VideoPoster_1280x720

A Luminescent Cell Viability Assay for Fast, Easy, Everyday Use

  • Reduced preparation time
  • Convenient repeat use over multiple days
  • Same great performance as classic CellTiter-Glo® Assay

Size

Catalog number selected: G9241

$ 120.00 Your price: Log In

Request a Sample
Not available in all countries
Add to Helix Add to Helix Add to Helix
CellTiter-Glo® 2.0 Assay
10ml
$ 120.00
Your price: Log In
Change Configuration
CellTiter-Glo_20_Overview-Background

CellTiter-Glo® 2.0 Measures ATP, a Key Indicator of Cell Health

CellTiter-Glo 2.0, based on the original CellTiter-Glo® Assay chemistry, is a single-reagent format with improved stability for convenient storage and simpler setup. Whether you perform assays in a single plate or process hundreds of plates at a time, the ready-to-use reagent is designed for fast and easy everyday use. A highly sensitive assay with broad linearity, it is amenable to high throughput screening and multiplex applications.

11542MD-W

The CellTiter-Glo® 2.0 Assay determines the number of viable cells in culture by quantifying ATP which indicates the presence of metabolicallly active cells. Luminesence readout is directly proportional to the number of viable cells in culture.

CellTiter-Glo_20_Foreground

Simple Assay Setup and Enhanced Stability

A single, ready-to-use reagent and simple "add-mix-measure" protocol means there's no need to mix components.

The CellTiter-Glo 2 reagent is stable at room temperature and at 4°C, allowing fast and easy assay implementation, and eliminating the thawing and mixing requiring with other ATP-based assays. Enhanced stability also allows for convenient storage.

11543MG-W
Percent Activity Remaining CellTiter-Glo® 2.0 Reagent Stability CellTiter-Glo® "Original" Reagent Stability
>85% Activity at 22°C 7 days 12 hours
>85% Activity at 4°C months 3.5 days

Assay Performance

The CellTiter-Glo 2.0 Viability Assay exhibits the same high performance as the classic CellTiter-Glo Assay, making it suitable for use from benchtop scale to high throughput screening.

11815MC-W-a
11815MC-W-b
11815MC-W-c

High sensitivity and broad linearity. Luminescence measured with the CellTiter-Glo® 2.0 Assay is proportional to the number of viable Jurkat cells in culture over three orders of magnitude in 96-well, 384-well and 1536-well plates.

Multiplex Capability

CellTiter-Glo 2.0 Assay can be multiplexed with other assays, reducing cell culture costs and labor. Multiplexing assays in the same sample well allows complementary measures of cell health to correct for errors in culturing, plating or assay chemistry interferences.

CellTox™ Green Cytotoxicity Reagent was applied to bortezemibtreated K562 cells after 48 hours of exposure. Fluorescence associated with cytotoxicity was measured, then CellTiter-Glo® 2.0 Reagent was added and the luminescence associated with viability was measured.

12023MB-W

Protocols

Specifications

You are viewing: G9241 Change Configuration

What's in the box?

Item Part # Size

CellTiter-Glo® 2.0 Reagent

G924A 1 x 10ml

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

CellTiter-Glo® 2.0 Reagent can maintain >85% activity upon storage at 4°C for 5 months or >85% activity upon storage at 22–25°C for 7 days. It can withstand four additional freeze-thaw cycles after the first thaw with no loss of activity when the reagent is stored at –30°C to –10°C.

Patents and Disclaimers

U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

U.S. Pat. Nos. 7,741,067, 8,361,739 and 8,603,767 and other patents and patents pending.

Patent Pending.

U.S. Pat. Nos. 6,602,677, 7,241,584, 8,030,017 and 8,822,170 and other patents and patents pending.

Specifications

You are viewing: G9242 Change Configuration

What's in the box?

Item Part # Size

CellTiter-Glo® 2.0 Reagent

G924B 1 x 100ml

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

CellTiter-Glo® 2.0 Reagent can maintain >85% activity upon storage at 4°C for 5 months or >85% activity upon storage at 22–25°C for 7 days. It can withstand four additional freeze-thaw cycles after the first thaw with no loss of activity when the reagent is stored at –30°C to –10°C.

Patents and Disclaimers

U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

U.S. Pat. Nos. 7,741,067, 8,361,739 and 8,603,767 and other patents and patents pending.

Patent Pending.

U.S. Pat. Nos. 6,602,677, 7,241,584, 8,030,017 and 8,822,170 and other patents and patents pending.

Specifications

You are viewing: G9243 Change Configuration

What's in the box?

Item Part # Size

CellTiter-Glo® 2.0 Reagent

G924C 1 x 500ml

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

CellTiter-Glo® 2.0 Reagent can maintain >85% activity upon storage at 4°C for 5 months or >85% activity upon storage at 22–25°C for 7 days. It can withstand four additional freeze-thaw cycles after the first thaw with no loss of activity when the reagent is stored at –30°C to –10°C.

Patents and Disclaimers

Patent Pending.

U.S. Pat. Nos. 6,602,677, 7,241,584, 8,030,017 and 8,822,170 and other patents and patents pending.

U.S. Pat. Nos. 7,741,067, 8,361,739 and 8,603,767 and other patents and patents pending.

U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

Resources

workflow-background

Small Molecule Drug Discovery Workflow

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom